BridgeBio Oncology Therapeutics, Inc.
BBOT
$9.71
$0.879.84%
NASDAQ
| 06/30/2025 | 03/31/2025 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | -28.44M | -22.06M | -21.82M | ||
| Total Depreciation and Amortization | 181.00K | 54.00K | 52.00K | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 486.00K | 944.00K | 1.29M | ||
| Change in Net Operating Assets | 4.48M | 1.46M | 12.33M | ||
| Cash from Operations | -23.29M | -19.60M | -8.16M | ||
| Capital Expenditure | -231.00K | -162.00K | -14.00K | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 9.87M | 15.53M | -151.49M | ||
| Cash from Investing | 9.64M | 15.37M | -151.50M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | 330.00K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | 22.22M | -- | 199.26M | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -3.27M | -404.00K | -- | ||
| Cash from Financing | 18.96M | -404.00K | 199.59M | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 5.30M | -4.64M | 39.93M | ||